The Indian pharmaceutical sector "was once notorious for making cheap knockoffs of Western medicines" to sell in developing countries, says the New York Times, but now it is a manufacturing center of drugs to sell worldwide. "What I see happening now is manufacturing and even packaging and even formulation are moving to India," says Jim Worrell, the chief executive of Pharma Services Network.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.